Beijing Sungen Biomedical Technology Co., Ltd

This study tested a new medicine called SGC001 in 38 people having a heart attack procedure. The goal was to see if it is safe and might reduce heart muscle damage and inflammation. Participants received either the drug or a placebo by IV once. The drug is not yet approved anywhe…

This early-stage study tested a single dose of the experimental drug SGC001 in 49 healthy adults to check its safety and how the body processes it. The drug is being developed for heart attacks, but this trial did not involve people with heart disease. The goal was to gather esse…